Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer. Reply.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- September 26, 2019
has subject area
- 11 Medical and Health Sciences (FoR)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Combined Modality Therapy (MeSH)
- General & Internal Medicine (Science Metrix)
- Genomics (MeSH)
- Humans (MeSH)
published in
- New England Journal of Medicine Journal